Clinical Trial

Effect of Adding Electroacupuncture to Anti-cancer Therapy-induced Peripheral Neuropathy

Recruiting
View on ClinicalTrials.gov →
Summary
This study is being done to evaluate the potential benefits of using electroacupuncture to reduce the severity of chemotherapy-induced peripheral neuropathy for patients with peripheral neuropathy after chemotherapy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-27.
Status change: Not Yet Recruiting → Recruiting 2025-04-15
Trial Details
NCT Number NCT06858709
Lead Sponsor Zhongnan Hospital
Conditions Chemotherapy-induced Peripheral Neuropathy (CIPN), Cancer
Enrollment 150 participants
Start Date 2025-03-20
Primary Completion 2027-01-15 (estimated)
Study Completion 2027-03-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-20